180 related articles for article (PubMed ID: 26959880)
1. Prp19 facilitates invasion of hepatocellular carcinoma via p38 mitogen-activated protein kinase/twist1 pathway.
Yin J; Wang L; Zhu JM; Yu Q; Xue RY; Fang Y; Zhang YA; Chen YJ; Liu TT; Dong L; Shen XZ
Oncotarget; 2016 Apr; 7(16):21939-51. PubMed ID: 26959880
[TBL] [Abstract][Full Text] [Related]
2. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
3. Prp19 Arrests Cell Cycle via Cdc5L in Hepatocellular Carcinoma Cells.
Huang R; Xue R; Qu D; Yin J; Shen XZ
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387715
[TBL] [Abstract][Full Text] [Related]
4. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
6. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1.
Zhu Y; Qu C; Hong X; Jia Y; Lin M; Luo Y; Lin F; Xie X; Xie X; Huang J; Wu Q; Qiu X; Piao D; Xing Y; Yu T; Lu Y; Huang Q; Yu C; Jin J; Zhang Z
Cell Death Differ; 2019 Jan; 26(2):306-320. PubMed ID: 29748601
[TBL] [Abstract][Full Text] [Related]
7. KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.
Han J; Wang F; Lan Y; Wang J; Nie C; Liang Y; Song R; Zheng T; Pan S; Pei T; Xie C; Yang G; Liu X; Zhu M; Wang Y; Liu Y; Meng F; Cui Y; Zhang B; Liu Y; Meng X; Zhang J; Liu L
Oncogene; 2019 Jan; 38(3):406-420. PubMed ID: 30115976
[TBL] [Abstract][Full Text] [Related]
8. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
[TBL] [Abstract][Full Text] [Related]
9. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin C-terminal Hydrolase 37, a novel predictor for hepatocellular carcinoma recurrence, promotes cell migration and invasion via interacting and deubiquitinating PRP19.
Fang Y; Fu D; Tang W; Cai Y; Ma D; Wang H; Xue R; Liu T; Huang X; Dong L; Wu H; Shen X
Biochim Biophys Acta; 2013 Mar; 1833(3):559-72. PubMed ID: 23220010
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinoma.
Xiao T; Zhang Q; Zong S; Zhong WL; Qin Y; Bi Z; Chen S; Liu HJ; Wei JJ; Zhou BJ; Wang LM; Zhou HG; Liu YR; Sun T; Yang C
J Exp Clin Cancer Res; 2018 Aug; 37(1):185. PubMed ID: 30081924
[TBL] [Abstract][Full Text] [Related]
12. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1.
Huang W; Chen Z; Shang X; Tian D; Wang D; Wu K; Fan D; Xia L
Hepatology; 2015 Jun; 61(6):1920-33. PubMed ID: 25704764
[TBL] [Abstract][Full Text] [Related]
13. SOX5 promotes epithelial-mesenchymal transition and cell invasion via regulation of Twist1 in hepatocellular carcinoma.
Wang D; Han S; Wang X; Peng R; Li X
Med Oncol; 2015 Feb; 32(2):461. PubMed ID: 25572815
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma.
Lv X; Zhao F; Huo X; Tang W; Hu B; Gong X; Yang J; Shen Q; Qin W
Med Oncol; 2016 Jul; 33(7):70. PubMed ID: 27262566
[TBL] [Abstract][Full Text] [Related]
15. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Du R; Wu S; Lv X; Fang H; Wu S; Kang J
J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP
Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767
[TBL] [Abstract][Full Text] [Related]
18. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T
Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
Chang RM; Xu JF; Fang F; Yang H; Yang LY
Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin C Interacts with TNF-α/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in Hepatocellular Carcinoma.
Zhang GP; Yue X; Li SQ
Cancer Res Treat; 2020 Jan; 52(1):10-23. PubMed ID: 31048666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
